trending Market Intelligence /marketintelligence/en/news-insights/trending/2NaDqjDqSrtGxIo9cA5soA2 content esgSubNav
In This List

Blackstone funds to buy Japan's AYUMI Pharmaceutical

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Podcast

Street Talk | Episode 99 - Higher rates punish bond portfolios, weigh on bank M&A

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch


Blackstone funds to buy Japan's AYUMI Pharmaceutical

Private equity funds managed by Blackstone Group LP agreed to purchase Japanese pharmaceutical company AYUMI Pharmaceutical Corp., marking the firm's first control private equity investment in the country.

The agreement was reached with local private equity firm Unison Capital Inc. and medical information site company M3 Inc.

Terms of the deal, expected to close in the second quarter, were not disclosed.

Bloomberg News earlier reported that Unison was evaluating a potential sale of the anti-rheumatic drug maker for up to US$1 billion.